4/17/2024

Ofloxacin Ophthalmic Solution

Products Affected - Description

- Ocuflox ophthalmic solution, Allergan (AbbVie), 5 mL bottle, 1 count, NDC 11980-0779-05
- Ofloxacin ophthalmic solution, Bausch Health, 10 mL bottle, 1 count, NDC 24208-0434-10
- Ofloxacin ophthalmic solution, Bausch Health, 5 mL bottle, 1 count, NDC 24208-0434-05

Reason for the Shortage

- AbbVie did not provide a reason for the shortage.
- Akorn ceased operations in February 2023.
- Apotex has ofloxacin ophthalmic solution available.
- Bausch Health did not provide a reason for the shortage.
- Rising has ofloxacin ophthalmic solution available.

Available Products

- Ofloxacin ophthalmic solution, Apotex, 10 mL bottle, 1 count, NDC 60505-0560-01
- Ofloxacin ophthalmic solution, Apotex, 5 mL bottle, 1 count, NDC 60505-0560-00
- Ofloxacin ophthalmic solution, Rising Pharmaceuticals, 10 mL bottle, 1 count, NDC 64980-0515-01
- Ofloxacin ophthalmic solution, Rising Pharmaceuticals, 5 mL bottle, 1 count, NDC 64980-0515-05

Estimated Resupply Dates

- AbbVie has Ocuflox 5 mL bottles on back order and the company cannot estimate a release date.
- Bausch Health has ofloxacin ophthalmic solution in 5 mL and 10 mL bottles on back order and the company estimates a release date of July 2024.

Updated

Updated April 17, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 22, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.